Details of the Drug

General Information of Drug (ID: DMQG7ZM)

Drug Name
Belagenpumatucel-L
Synonyms Lucanix (TN)
Indication
Disease Entry ICD 11 Status REF
Non-small-cell lung cancer 2C25.Y Phase 3 [1]
Small-cell lung cancer 2C25.Y Phase 3 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D03OTH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
TGF beta-2 messenger RNA (TGFB2 mRNA) TTI0KH6 TGFB2_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Non-small-cell lung cancer
ICD Disease Classification 2C25.Y
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
TGF beta-2 messenger RNA (TGFB2 mRNA) DTT TGFB2 1.51E-17 -0.53 -0.77
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00676507) Phase III Lucanix Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy. U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug id 590662).